InvestorsHub Logo

misiu143

06/15/21 2:12 PM

#170457 RE: Learning53 #170452

HEY , HEY Learning..

Great article , I love this story and many others like that..
To me tocilizumab is not even close with efficacy to leronlimab , and what a possible side effects..

Yes , lets start in Brazil , hopefully without corruption , nice clean study with up to 4 doses and see what our drug will do..

I cant wait..

And all imo.